We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+1.34%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$42.2B
AUM Growth
-$1.23B
(-2.8%)
Cap. Flow
-$952M
Cap. Flow
% of AUM
-2.26%
Top 10 Holdings %
Top 10 Hldgs %
14.57%
Holding
2,171
New
150
Increased
772
Reduced
960
Closed
152
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$156M |
| 2 |
Prologis
PLD
|
+$150M |
| 3 |
Chevron
CVX
|
+$109M |
| 4 |
Qualcomm
QCOM
|
+$101M |
| 5 |
Paycom
PAYC
|
+$90.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
+$230M |
| 2 |
Kimberly-Clark
KMB
|
+$160M |
| 3 |
Stanley Black & Decker
SWK
|
+$130M |
| 4 |
Paychex
PAYX
|
+$113M |
| 5 |
Dominion Energy
D
|
+$105M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.81% |
| 2 | Healthcare | 17.11% |
| 3 | Financials | 12.73% |
| 4 | Industrials | 9.87% |
| 5 | Consumer Discretionary | 9.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1251
Evercore
EVR
$10.1B
| $633K | ﹤0.01% |
3,036
-641
| -17% | -$125K |
|
1252
RLJ Lodging Trust
RLJ
$1.65B
| $632K | ﹤0.01% |
65,602
-3,219
| -5% | -$33.9K |
|
1253
Paylocity
PCTY
$7.82B
| $630K | ﹤0.01% |
4,779
-185
| -4% | -$28.6K |
|
1254
DNOW Inc
DNOW
$2.82B
| $628K | ﹤0.01% |
45,748
| – | – |
|
1255
Novavax
NVAX
$1.54B
| $626K | ﹤0.01% |
49,428
+4,045
| +9% | +$40.7K |
|
1256
Starwood Property Trust
STWD
$5.55B
| $626K | ﹤0.01% |
33,038
-1,285
| -4% | -$25K |
|
1257
Sensata Technologies
ST
$6.1B
| $620K | ﹤0.01% |
16,593
+3,948
| +31% | +$152K |
|
1258
First American
FAF
$7.26B
| $617K | ﹤0.01% |
11,435
-223
| -2% | -$12.4K |
|
1259
Valvoline
VVV
$3.46B
| $615K | ﹤0.01% |
14,237
+3,263
| +30% | +$137K |
|
1260
Essent Group
ESNT
$6.1B
| $615K | ﹤0.01% |
10,939
-522
| -5% | -$29K |
|
1261
MACOM Technology Solutions
MTSI
$19.2B
| $613K | ﹤0.01% |
5,502
-227
| -4% | -$23.1K |
|
1262
Pacific Biosciences
PACB
$417M
| $612K | ﹤0.01% |
+446,854
| New | +$902K |
|
1263
Valmont Industries
VMI
$9.18B
| $611K | ﹤0.01% |
2,228
-216
| -9% | -$52.7K |
|
|
AZPN
1264
DELISTED
Aspen Technology Inc
AZPN
| $611K | ﹤0.01% |
3,077
+707
| +30% | +$145K |
|
1265
Concrete Pumping Holdings
BBCP
$508M
| $606K | ﹤0.01% |
100,851
| – | – |
|
|
JNPR
1266
DELISTED
Juniper Networks
JNPR
| $605K | ﹤0.01% |
16,591
+762
| +5% | +$27.1K |
|
1267
United Bankshares
UBSI
$6.44B
| $604K | ﹤0.01% |
18,631
-1,454
| -7% | -$48.1K |
|
1268
Oshkosh
OSK
$8.95B
| $604K | ﹤0.01% |
5,581
-1,897
| -25% | -$219K |
|
1269
Dropbox
DBX
$8.21B
| $603K | ﹤0.01% |
26,849
-8,099
| -23% | -$185K |
|
1270
Houlihan Lokey
HLI
$9.11B
| $601K | ﹤0.01% |
4,460
-134
| -3% | -$17.5K |
|
1271
Marriott Vacations Worldwide
VAC
$3.49B
| $594K | ﹤0.01% |
6,805
-1,395
| -17% | -$132K |
|
1272
Teradata
TDC
$2.71B
| $593K | ﹤0.01% |
17,157
-685,651
| -98% | -$23.9M |
|
1273
Lithia Motors
LAD
$7.46B
| $586K | ﹤0.01% |
2,322
-207
| -8% | -$54.2K |
|
1274
Exelon
EXC
$43.7B
| $583K | ﹤0.01% |
16,856
+11,098
| +193% | +$410K |
|
|
CWEN.A
1275
DELISTED
Clearway Energy Class A
CWEN.A
| $583K | ﹤0.01% |
25,727
+10,307
| +67% | +$241K |
|
Similar funds
Federated Hermes's Q2 2024 Portfolio in Review
As of Q2 2024, Federated Hermes held 2,171 positions worth $42.2B, down 2.8% from $43.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes's Q2 2024 filing shows 150 new, 772 increased, 960 reduced and 152 closed positions. Its largest new stake was Loar Holdings: 729,296 shares worth $39M. The largest sale was Fusion Pharmaceuticals Inc. Common Shares, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Federated Hermes's largest Q2 2024 buy was Loar Holdings: 729,296 shares worth $39M.
- Federated Hermes added most to Bristol-Myers Squibb in Q2 2024, an estimated $156M increase.
- Federated Hermes's biggest Q2 2024 reduction was Kimberly-Clark, cutting an estimated $160M.
- Federated Hermes fully exited Fusion Pharmaceuticals Inc. Common Shares in Q2 2024, selling an estimated $230M.
- Federated Hermes's ten largest holdings make up 15% of its $42.2B portfolio in Q2 2024.
- Federated Hermes opened 150 new positions and closed 152 in Q2 2024.
- Federated Hermes's portfolio value fell 2.8% quarter-over-quarter to $42.2B.
Based on Federated Hermes's 13F filing for Q2 2024, filed 8 Aug 2024.